Ignite Creation Date:
2024-06-16 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 3:30 PM
Study NCT ID:
NCT06435429
Status:
RECRUITING
Last Update Posted:
2024-05-30
First Post:
2024-05-24
Brief Title:
A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab Each in Combination With Physicians Choice Chemotherapy for the Treatment of Participants With Metastatic HER2-positive Breast Cancer
Sponsor:
Jazz Pharmaceuticals
Organization:
Jazz Pharmaceuticals
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-16
Start Date Type:
ESTIMATED
Primary Completion Date:
2031-04-25
Primary Completion Date Type:
ESTIMATED
Completion Date:
2031-04-25
Completion Date Type:
ESTIMATED
First Submit Date:
2024-05-24
First Submit QC Date:
May 24 2024
Study First Post Date:
2024-05-30
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-08-26
Last Update Post Date:
2024-05-30
Last Update Post Date Type:
ACTUAL